Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -15.55%173.4M | -20.68%172.16M | -18.56%169.79M | 8.13%838.13M | -5.61%207.27M | -8.70%205.33M | 17.97%217.04M | 42.14%208.49M | 67.96%775.15M | 51.87%219.59M |
| Cost of revenue | -16.41%163.99M | -21.66%161.68M | -19.62%159.85M | 7.02%799.29M | -7.83%197.85M | -9.34%196.19M | 17.07%206.37M | 42.56%198.88M | 61.68%746.83M | 31.61%214.66M |
| Gross profit | 2.89%9.41M | -1.84%10.48M | 3.35%9.93M | 37.18%38.84M | 90.84%9.42M | 7.60%9.14M | 38.49%10.67M | 33.90%9.61M | 7,054.85%28.31M | 126.64%4.93M |
| Operating expense | 7.98%4.48M | 4.77%4.29M | 13.55%4.87M | 19.08%17.22M | 115.53%4.79M | 3.52%4.15M | -6.21%4.09M | 10.83%4.29M | 11.13%14.46M | -30.18%2.22M |
| Selling and administrative expenses | 5.93%4.22M | -2.54%3.95M | 11.06%4.76M | 17.85%16.78M | 124.39%4.54M | -0.45%3.98M | -6.76%4.06M | 10.89%4.29M | 10.33%14.24M | -36.19%2.02M |
| -General and administrative expense | 5.93%4.22M | -2.54%3.95M | 11.06%4.76M | 17.85%16.78M | 124.39%4.54M | -0.45%3.98M | -6.76%4.06M | 10.89%4.29M | 10.33%14.24M | -36.19%2.02M |
| Other operating expenses | 56.55%263K | 827.78%334K | 5,350.00%109K | 96.03%445K | 26.00%252K | 1,766.67%168K | 176.92%36K | -50.00%2K | 102.78%227K | 1,334.41%200K |
| Operating profit | -1.34%4.93M | -5.94%6.19M | -4.87%5.06M | 56.08%21.62M | 70.62%4.63M | 11.25%4.99M | 96.83%6.58M | 60.88%5.32M | 203.20%13.85M | 112.50%2.71M |
| Net non-operating interest income (expenses) | 8.06%-3.58M | 4.44%-3.68M | -6.41%-3.75M | -16.91%-13.21M | -9.48%-3.88M | -21.54%-3.89M | -20.09%-3.85M | -26.27%-3.52M | -64.39%-11.3M | -126.84%-3.54M |
| Non-operating interest income | ---- | ---- | ---- | 35.36%1.95M | ---- | ---- | ---- | ---- | 52.71%1.44M | ---- |
| Non-operating interest expense | -8.06%3.58M | -4.44%3.68M | 6.41%3.75M | 19.00%15.16M | 9.48%3.88M | 21.54%3.89M | 20.09%3.85M | 26.27%3.52M | 62.98%12.74M | 41.35%3.54M |
| Net investment income | 21.67%46.23K | -56.00%37.99K | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 352.65%212.16K | 724.89%46.87K | ||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -74.11%584.24K | 55.07%2.26M | ||||||||
| Less:Other special charges | ---- | ---- | ---- | 74.11%-584.24K | ---- | ---- | ---- | ---- | -55.07%-2.26M | ---- |
| Other non-operating income (expenses) | 8.31%769K | 16.10%887K | 20.37%709K | 11.44%529.1K | -33.58%1.34M | -8.03%710K | -26.18%764K | 35.09%589K | 536.03%474.8K | 214.20%2.02M |
| Income before tax | 16.92%2.12M | -2.78%3.4M | -15.28%2.02M | 82.21%9.78M | 76.14%2.09M | -12.01%1.81M | 198.12%3.49M | 150.31%2.39M | 128.74%5.37M | 105.05%1.19M |
| Income tax | -15.10%568K | 42.09%1.43M | -56.70%307K | 125.93%3.31M | 29.53%930K | 418.60%669K | 261.51%1.01M | 107.92%709K | 147.09%1.47M | 114.49%718K |
| Net income | 35.70%1.55M | -20.89%1.97M | 2.20%1.72M | 65.78%6.47M | 147.65%1.16M | -40.84%1.14M | 178.41%2.49M | 173.90%1.68M | 125.07%3.9M | 102.53%468K |
| Net income continuous operations | 35.70%1.55M | -20.89%1.97M | 2.20%1.72M | 65.78%6.47M | 147.65%1.16M | -40.84%1.14M | 178.41%2.49M | 173.90%1.68M | 125.07%3.9M | 102.53%468K |
| Noncontrolling interests | 300.71%281K | -164.63%-380K | -1,113.86%-1.02M | -440.14%-1.39M | -322.55%-1.93M | -3.70%-140K | 240.00%588K | 6.32%101K | 292.86%409.32K | 1,763.79%869K |
| Net income attributable to the company | -1.09%1.27M | 23.57%2.35M | 73.64%2.74M | 125.08%7.86M | 871.32%3.09M | -37.92%1.28M | 44.67%1.9M | 204.63%1.58M | 122.75%3.49M | 97.83%-401K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -1.09%1.27M | 23.57%2.35M | 73.64%2.74M | 125.08%7.86M | 871.32%3.09M | -37.92%1.28M | 44.67%1.9M | 204.63%1.58M | 122.75%3.49M | 97.83%-401K |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -5.56%0.0017 | 22.22%0.0033 | 72.73%0.0038 | 0.00%0.01 | 816.67%0.0043 | -40.00%0.0018 | 42.11%0.0027 | 175.00%0.0022 | 150.00%0.01 | 97.58%-0.0006 |
| Diluted earnings per share | -5.56%0.0017 | 22.22%0.0033 | 72.73%0.0038 | 0.00%0.01 | 816.67%0.0043 | -40.00%0.0018 | 42.11%0.0027 | 175.00%0.0022 | 150.00%0.01 | 97.58%-0.0006 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.